Back to Our Science

The challenges of developing inhaled generics medicines – Martin Oliver


Release date:18/12/2020


What are the unique challenges involved in developing inhaled generic medicines? Following the US FDA’s approval of VR315 (US), hear from Martin Oliver, our SVP Delivery Management – DPI and pMDI Platforms, as he explains in this podcast.

You can follow our podcast at or subscribe it on Spotify, Apple or Google Podcasts.

Back to Our Science